| |
|
|
|
Urovant Sciences Ltd.  
|
|
9.13 -0.07 (-0.01%) |
07-14 15:10 |
|
Open: |
9.13 |
Pre close: |
9.2 |
Target:
|
12.68 
|
|
High: |
9.43 |
Low: |
9.0864 |
Resistance:
|
10.86
11.95
|
|
Volume: |
53,456 |
Market Cap: |
281M |
Support:
|
9.09
7.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.44
|
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
10.23 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
9.98 |
Stochastic Oscillator |
%K(14,3):
|
5.93  |
|
MA(250): |
10.34 |
%D(3): |
5.11 |
|
Average Volume(K) |
3-Month: |
8207
|
52-Week |
High:
|
15.98 |
|
10-Days: |
5586 |
Low: |
6.55 |
|
RSI |
RSI(14):
|
39.07 |
Change(%): |
9.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.820 |
Return on Equity (ttm) |
-1750.7 |
Shares Out. (M) |
30.52 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-106.1 |
Shares Float (M) |
5.47 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
77.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
25.99 |
|
Forward EPS |
-4.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
882 |
|
Book Value (p.s.) |
-1.890 |
EBITDA (p.s.) |
-4.538 |
P/E |
-1.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-102.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-43.02 |
P/CF |
-2.76 |
|
|
|
|
|
|
